首页 | 本学科首页   官方微博 | 高级检索  
     

脂微球前列腺素E1与丹参对2型糖尿病患者NO、ET的对比研究
引用本文:杨宇红,张如根,黄珊,邵侃. 脂微球前列腺素E1与丹参对2型糖尿病患者NO、ET的对比研究[J]. 中国临床医学, 2005, 12(2): 307-309
作者姓名:杨宇红  张如根  黄珊  邵侃
作者单位:上海长宁区中心医院,内分泌科,上海,200336
摘    要:目的:比较2型糖尿病(type 2 Diabetics,T2DM)患者应用脂微球前列腺素E1(Lipo PGE1)和丹参后其血浆一氧化氮(nitric oxide,NO)、内皮素(endothelin,ET)的变化。方法:66例糖尿病患者,按1999年WHO糖尿病诊断标准确认,随机分为两组:Lipo PGE1组和丹参组。两组患者临床检查均无严重心、肾、脑等并发症。ET 1 以放射免疫法测定,NO以硝酸还原法测定。结果:(1)两组T2DM患者的年龄、病程、体重指数(BMI)、收缩压、舒张压、胆固醇、甘油三酯、尿素氮、肌酐、空腹及餐后2h胰岛素、C 肽值均无显著差异。(2)两组T2DM患者用药前空腹及餐后2h血糖无显著差异,治疗2 周后两组空腹及餐后2h血糖亦无显著差异,但均比用降糖药前明显下降,有显著差异。治疗前,PEG1 组无论空腹还是餐后2 hET值均高于丹参组,而NO水平低于丹参组。经2周治疗后,丹参组ET值仅见餐后2 h有显著下降, P<0.05,余未见变化;而PEG1 组不论空腹,还是餐后2hET值均见有极显著下降, P均<0.001,且NO水平也显著升高,P均<0.05。结论:两组T2DM患者在降糖幅度相当的前提下,应用Lipo PGE1在糖尿病患者中能降低ET水平,提高NO浓度,丹参针剂未见相同结果,提示该药物不仅能直接扩张血管作用,而且还能调节ET及NO水平的间接效果,Lipo PGE1明显优于丹参针剂。

关 键 词:脂微球前列腺素E1 2型糖尿病患者 对比研究 餐后2h血糖 放射免疫法测定 血浆一氧化氮 Lipo PGE1 T2DM NO水平 扩张血管作用 PEG1 0.05 丹参针剂 1999年 硝酸还原法 临床检查 ET-1 体重指数 甘油三酯 ET水平 NO浓度 空腹
文章编号:1008-6358(2005)02-0307-03

Compaison Study of Endothelin (ET) and Nitric Oxide (NO) after Applying LipoPGE1 and Danshen on Type 2 Diabetics
YANG Yuhong ZHANG Rugen HUANG Shan,et al.. Compaison Study of Endothelin (ET) and Nitric Oxide (NO) after Applying LipoPGE1 and Danshen on Type 2 Diabetics[J]. Chinese Journal Of Clinical Medicine, 2005, 12(2): 307-309
Authors:YANG Yuhong ZHANG Rugen HUANG Shan  et al.
Abstract:Objective: The aim studied the change of the level in ET and No after applying lipoPGE1 and DanShen on type 2 diabetics. Methods: 66 diabetics patients were confirmed according to the diagnostic criteriom issued by WHO in 1999. And the patients were divided into two groups at random.:LipoPGE1 and Dan-Shen.ET-1 determination:radilimmunoassy.NO determination:nitric-reductive assay. Results: (1)Age,during, systolic and diastolic pressure, cholesterol, triglyceride, urea nitrogen, creatinine, limosis and postcibum (2 hours later) insulin and C-peptide in the 2 groups have insignificant difference. (2)blood glucose of both limosis and postcibum(2 hours later) in 2 groups before and after administration antidiabetic medicine have insignificant change. Two week later, blood glucose declined significantly, P<0.01. ET concentration of both limosis and postcibum (2 hours later) after lipo-PGE1,administration declined significantly, P<0.001. NO level rised significantly, P<0.05.Only postcibum (2 hours later) ET after Qan- Shen administration declined significantly,P< 0.05.Conclusion:The study shows that lipoPGE1 can significantly decrease ET and increase NO Concentration, which suggests that lipoPGE1 could not only extend blood vessel directly, but also could adjust the level of ET and NO. LipoPGE1 is excellent than Dan-Sheng solution.
Keywords:Endothelin  Nitric oxide  Type 2 diabetics  LipoPGE1
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号